Medicover AB (publ) delivers healthcare and diagnostic solutions across multiple countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. The company operates through two primary divisions: Healthcare Services and Diagnostic Services. Its extensive diagnostic portfolio includes a wide range of analyses such as allergy and autoimmune tests, bacteriology, parasitology, biochemistry, immunochemistry, blood group identification/transfusion medicine, tumor markers, clinical chemistry, cytology, hematology, histopathology, human genetics, hygiene, immunology, infectious disease detection, microbiology, molecular biology, and pharmacology/toxicology. Medicover's operational infrastructure spans 10 countries, featuring 97 clinical laboratories, 733 blood collection points, and 26 outpatient clinics dedicated to diagnostics. Complementing this are its healthcare facilities, which include 117 medical centers, 20 fertility treatment clinics, 52 dental practices, 25 hospitals, and 25 fitness facilities. It caters to a diverse client base comprising corporate entities, private individuals, patients, and public sector payers. Founded in 1995, Medicover AB (publ) maintains its headquarters in Stockholm, Sweden.